-
Missing the MarkOnly one-third of new cancer therapies or drug combinations tested in phase III clinical trials prove to be better than the standard of care. Researchers explain why and how they are aiming to improve the odds.
by Sue Rochman
-
Healthy Habits
Going With the GrainA fiber-rich diet can reduce cancer risk.
by Alanna Kennedy-Gorman
-
Forward Look
Bridging the DistanceQ&A with medical oncologist Ana MarÃa López, medical director of the telemedicine program at the University of Arizona Cancer Center in Tucson.
by Sue Rochman
-
Forward Look
Treading Carefully With Medical ScansTo reduce your long-term cancer risk, make sure the tests are justified.
by Ingfei Chen
-
Forward Look
A Trojan Horse to Fight CancerAn experimental treatment shows the potential of a new family of targeted drugs.
by Stephen Ornes
-
Forward Look
Common-Sense ScreeningSigmoidoscopy may be a good option for colorectal cancer screening.
by Sue Rochman
-
Forward Look
Task Force Says “No” to PSA for Prostate Cancer ScreeningExpert panel's recommendation spurs debate.
by Stephen Ornes
-
Stranger in a Strange LandCancer puts everyone in foreign territory, but those diagnosed with a rare form of the disease may feel the most lost without clear guidance toward the best care or support from other survivors. Four steps can help ease the way.
by Rabiya S. Tuma
-
A Genetic LegacyDoctors now know more than ever about the inherited cancer-related mutations that can link generations of family members. But with the new knowledge from scientific advances and DNA testing come new questions for patients.
by Sue Rochman
-
Healthy Habits
A Healthy StartA well-balanced diet can reduce a child's adult cancer risk.
by Alanna Kennedy-Gorman
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
-
Using Lymphocytes to Attack TumorsSooner rather than later may be the best strategy for using an experimental treatment for advanced melanoma.
-
Closing Disparities Through Genetic TestingOlufunmilayo Olopade seeks widespread use of testing to encourage prevention and early detection of deadly cancers.
Learning Medicare’s ABCDs
